Replies to post #1954 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

These were nuke-suppressed patients, so their viral-load levels for both DNA and RNA were already very low at baseline.

Thanks Dew. I didn't realize that. Makes sense that it would be harder to lower several logs from an already low baseline.

We’ll get a read on the viral-load-reducing efficacy of EDP-514 in the separate trial in viremic patients.

I will look forward to that data.